Abstract
BackgroundTumor necrosis factor-α (TNF-α), a proinflammatory cytokine, is capable of activating the small GTPase RhoA, which in turn contributes to endothelial barrier dysfunction. However, the underlying signaling mechanisms remained undefined. Therefore, we aimed to determine the role of protein kinase C (PKC) isozymes in the mechanism of RhoA activation and in signaling TNF-α-induced mouse brain microvascular endothelial cell (BMEC) barrier dysfunction.MethodsBend.3 cells, an immortalized mouse brain endothelial cell line, were exposed to TNF-α (10 ng/mL). RhoA activity was assessed by pull down assay. PKC-α activity was measured using enzyme assasy. BMEC barrier function was measured by transendothelial electrical resistance (TER). p115RhoGEF phosphorylation was detected by autoradiography followed by western blotting. F-actin organization was observed by rhodamine-phalloidin staining. Both pharmacological inhibitors and knockdown approaches were employed to investigate the role of PKC and p115RhoGEF in TNF-α-induced RhoA activation and BMEC permeability.ResultsWe observed that TNF-α induces a rapid phosphorylation of p115RhoGEF, activation of PKC and RhoA in BMECs. Inhibition of conventional PKC by Gö6976 mitigated the TNF-α-induced p115RhoGEF phosphorylation and RhoA activation. Subsequently, we found that these events are regulated by PKC-α rather than PKC-β by using shRNA. In addition, P115-shRNA and n19RhoA (dominant negative mutant of RhoA) transfections had no effect on mediating TNF-α-induced PKC-α activation. These data suggest that PKC-α but not PKC-β acts as an upstream regulator of p115RhoGEF phosphorylation and RhoA activation in response to TNF-α. Moreover, depletion of PKC-α, of p115RhoGEF, and inhibition of RhoA activation also prevented TNF-α-induced stress fiber formation and a decrease in TER.ConclusionsTaken together, our results show that PKC-α phosphorylation of p115RhoGEF mediates TNF-α signaling to RhoA, and that this plays a critical role in signaling F-actin rearrangement and barrier dysfunction in BMECs.
Highlights
Tumor necrosis factor-a (TNF-a), a proinflammatory cytokine, is capable of activating the small GTPase RhoA, which in turn contributes to endothelial barrier dysfunction
RhoA serves as a molecular switch, cycling between active GTP-bound and inactive GDP-bound states regulated by a large number of activators and inactivators, including guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and guanine nucleotide dissociation inhibitors (GDIs)
We found that depletion of protein kinase C (PKC)-a by Gö6976 or PKCa-ShRNA prevented the phosphorylation of p115RhoGEF in response to TNF-a, whereas depletion of PKC-b by PKCb-ShRNA had no effect on p115RhoGEF phosphorylation (Figure 4A)
Summary
Tumor necrosis factor-a (TNF-a), a proinflammatory cytokine, is capable of activating the small GTPase RhoA, which in turn contributes to endothelial barrier dysfunction. We aimed to determine the role of protein kinase C (PKC) isozymes in the mechanism of RhoA activation and in signaling TNF-a-induced mouse brain microvascular endothelial cell (BMEC) barrier dysfunction. Tumor necrosis factor-a (TNF-a) is released in large amounts by macrophages, monocytes and other leukocytes in kinase by pretreatment with Y-27632 alleviates brain edema in animals after TNF-a challenge [4]. These findings suggest an essential role for the RhoA/Rho kinase pathway in the regulation of TNF-a-induced BMECs barrier dysfunction. These studies suggest that TNF-a induces BMEC hyperpermeability, possibly through a p115RhoGEF/ RhoA-dependent mechanism
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have